Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant

BACKGROUND. Lung transplant patients are vulnerable to various forms of allograft injury, whether from acute rejection (AR) (encompassing acute cellular rejection [ACR] and antibody-mediated rejection [AMR]), chronic lung allograft dysfunction (CLAD), or infection (INFXN). Previous research indicate...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenheck, Justin P., Ross, David J., Botros, Mena, Wong, Alexander, Sternberg, Jonathan, Chen, Yen-An, Liang, Nathan, Baer, Amy, Ahmed, Ebad, Swenerton, Ryan, Zimmermann, Bernhard G., Fehringer, Gordon, Demko, Zachary P., Olymbios, Michael, Billings, Paul R., Keller, Brian C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Lung Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963832/
https://www.ncbi.nlm.nih.gov/pubmed/35372675
http://dx.doi.org/10.1097/TXD.0000000000001317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963832/
https://www.ncbi.nlm.nih.gov/pubmed/35372675
http://dx.doi.org/10.1097/TXD.0000000000001317

Ejemplares similares